CLINICAL-TRIAL ADRIAMYCIN (NSC-123127) IN ADVANCED SARCOMAS

被引：27

作者：

CREAGAN, ET ^{[1
]}

HAHN, RG ^{[1
]}

AHMANN, DL ^{[1
]}

BISEL, HF ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55901

来源：

关键词：

D O I：

10.1159/000225192

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：90 / 91

页数：2

共 9 条

[1] BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO
[2] 2-M
[3] ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY
BLUM, RH
CARTER, SK
[J]. ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) : 249 - 259
[4] ADRIAMYCIN - REVIEW
CARTER, SK
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) : 1265 - 1274
[5] AMPUTATION AND ADRIAMYCIN IN PRIMARY OSTEOSARCOMA
CORTES, EP
HOLLAND, JF
WANG, JJ
SINKS, LF
BLOM, J
SENN, H
BANK, A
GLIDEWELL, O
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) : 998 - 1000
[6] MIDDLEMAN E, 1971, CANCER-AM CANCER SOC, V28, P844, DOI 10.1002/1097-0142(1971)28:4<844::AID-CNCR2820280407>3.0.CO
[7] 2-9
[8] OBRYAN RM, 1973, CANCER-AM CANCER SOC, V32, P1, DOI 10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO
[9] 2-X